Does TIRZEPATIDE Cause Injection site mass? 1,386 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,386 reports of Injection site mass have been filed in association with TIRZEPATIDE (Zepbound). This represents 1.4% of all adverse event reports for TIRZEPATIDE.
1,386
Reports of Injection site mass with TIRZEPATIDE
1.4%
of all TIRZEPATIDE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Injection site mass From TIRZEPATIDE?
Of the 1,386 reports, 5 (0.4%) required hospitalization.
Is Injection site mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIRZEPATIDE. However, 1,386 reports have been filed with the FAERS database.
What Other Side Effects Does TIRZEPATIDE Cause?
Incorrect dose administered (23,301)
Injection site pain (10,989)
Nausea (10,018)
Off label use (7,007)
Extra dose administered (6,774)
Diarrhoea (5,463)
Vomiting (4,635)
Injection site haemorrhage (4,389)
Accidental underdose (3,897)
Injection site erythema (3,844)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
DUPILUMAB (2,243)
GLATIRAMER (2,172)
ETANERCEPT (2,101)
NALTREXONE (1,849)
LEUPROLIDE (1,359)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
OCTREOTIDE (880)
Which TIRZEPATIDE Alternatives Have Lower Injection site mass Risk?
TIRZEPATIDE vs TISAGENLECLEUCEL
TIRZEPATIDE vs TISLELIZUMAB
TIRZEPATIDE vs TISOTUMAB VEDOTIN
TIRZEPATIDE vs TISOTUMAB VEDOTIN-TFTV
TIRZEPATIDE vs TITANIUM DIOXIDE\ZINC